Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on September 1, 2008

Papers In Press, published online ahead of print May 9, 2008
J. Lipid Res., doi:10.1194/jlr.M800162-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M800162-JLR200v1
49/9/2045    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renner, O.
Right arrow Articles by Stange, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renner, O.
Right arrow Articles by Stange, E. F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 31, 2008
Revised on May 8, 2008
Accepted on May 9, 2008

Reduced ileal expression of organic solute transporter alpha and beta (OSTalpha -OSTbeta ) in non-obese gallstone disease

Olga Renner, Simone Harsch, André Strohmeyer, Silke Schimmel, and Eduard F. Stange

Department of Internal Medicine I, Robert-Bosch-Hospital, Stuttgart 70376

Corresponding Author: eduard.stange{at}rbk.de

Cholelithiasis is a multifactorial process and several mechanisms have been postulated. A decreased expression of the ileal apical sodium-dependent bile acid transporter (ASBT) and of the cytosolic ileal lipid binding protein (ILBP) was recently described in female non-obese patients. The role of the recently identified organic solute transporter (OSTa-OSTß) in gallstone pathogenesis remains still unclear. Therefore we performed analysis of OSTa-OSTß in gallstone patients, regarding body weight. Ileal mucosal biopsies were collected during routinely colonoscopy from female gallstone carriers (n=19) and controls (n=34). OSTa-OSTß mRNA expression was measured using the LightCycler sequence detection system; protein was analyzed by immunohistochemistry and Western blot. The mRNA expression of OSTa-OSTß was significantly (OSTa: 3.3-fold, p=0.006; OSTß: 2.6-fold, p=0.03) reduced in normal weight but not overweight gallstone carriers compared to controls. OSTa-OSTß protein levels also showed a reduction by 40-67%. The expression of OSTa-OSTß correlated positively with ASBT (r=0.65; 0.58, respectively), ILBP (r=0.77; 0.67), the farnesoid X receptor (FXR) (r=0.58; 0.50). Fibroblast growth factor-19 (FGF-19) showed a 2.8-fold (p=0.06) and liver receptor homolog-1 (LRH-1) a 2.0-fold reduction (p=0.04) in non-obese patients. In conclusion, an impaired function of all three ileal bile acid transporters may lead to low ileal bile acid reabsorption, an altered bile acid pool composition and therefore contribute to the formation of gallstones in non-obese.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
P. A. Dawson, T. Lan, and A. Rao
Bile acid transporters
J. Lipid Res., December 1, 2009; 50(12): 2340 - 2357.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement